Skip to main content
Premium Trial:

Request an Annual Quote

ASHG: Mona Miller

The American Society of Human Genetics said that Mona Miller will be stepping down from her role as CEO following the ASHG 2023 Annual Meeting in November. Miller has served as CEO for six years. ASHG said it will execute a plan to ensure full continuity through the executive transition, and that a search committee, chaired by President-elect Bruce Gelb, will pursue and select a permanent replacement for Miller.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.